Adaptive Biotechnologies ADPT Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
Based on the most recent quarter.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's cash ratio?
- Adaptive Biotechnologies (ADPT) reported cash ratio of 0.9× in Q1 2026.
- How has Adaptive Biotechnologies's cash ratio changed year-over-year?
- Adaptive Biotechnologies's cash ratio increased by 54.6% year-over-year, from 0.6× to 0.9×.
- What is the long-term trend for Adaptive Biotechnologies's cash ratio?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's cash ratio has grown at a -7.7% compound annual growth rate (CAGR), from 1.2× to 0.8×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.